chrisvoncsefalvay/vaers-outcomes huggingface dataset:
crying; feeling nausea; depression; feeling dizziness; This is a spontaneous report from a contactable consumer (patient's wife). An 80-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 17May2021 09:00 (Batch/Lot Number: ER8729) as 1st dose, single for covid-19 immunization. Medical history included heart valve replacement from 12Mar2021, kidney infection, had a heart bypass and is diabetic. The patient has no concomitant medications. The patient got the Pfizer Covid Vaccine on 17May2021, and the next day (18May2021) he woke up with dizziness. The reporter asked how long the symptoms last after the Covid vaccine. He is sort of getting nausea when he tries to get up. He was also real depressed. It kind of started the next day after the vaccine (18May2021), but Wednesday she was concerned because the patient was crying a lot which is unusual for him. The nausea started today (25May2021). He hasn't been up and about. The dizziness is about the same. They called his primary caregiver who started him on some antidepressants. She picked up the information sheet that was given to them with the Covid vaccine and read there that dizziness was a side effect and a feeling of impending doom which is sort of how he was feeling. Now that's why she was wondering when the symptoms would be over. She doesn't really think he needs anything. He has never been depressed. She thinks now it is a side effect from the vaccine. She thinks the depression has improved. He is not crying anymore, but somebody is with him all the time. This was his first dose of the vaccine. He is supposed to go back on 07Jun2021 for his second. The outcome the event depression was recovering, event crying was recovered on an unspecified date and the other events was not recovered.
Pain in hip and pelvic joints started the evening after vaccine was administered (7/31/2023).  The next morning (8/1/2023), the joint pain was so severe she was in tears and could barely walk. As her mother, I called the pediatrian who administered the vaccine at Clinic. The Pediatrican, Dr instructed us to go immediately to the Hospital ER. There patient was examed.
Fever 101.8, diarrhea, chills, muscle pain on Day 2. Hematoma day 3. Large hives with pain 2" from needle stick on day 9.
39 degree fever, chills, headache, aches.  Feels every bit as bad as when I had COVID 19 in March 2021
Positive test 30Jun; Positive test 30Jun; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: EN6199), in left arm, on 24May2021 as dose 2, single (Lot number: LR2613), in left arm, on 06Oct2021 as dose 3 (booster), single (Lot number: FF2588), in left arm and on 05May2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: Other medical history: HTN (Hypertension), controlled. Otherwise good physical condition. Concomitant medication(s) included: ATORVASTATIN, start date: Jan1999; LISINOPRIL, start date: Jan2009; TESTOSTERONE, start date: Jan2011; CLARITIN [LORATADINE], start date: Jan2020. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 30Jun2022, outcome "not recovered" and all described as "Positive test 30Jun". The patient underwent the following laboratory tests and procedures: Oxygen saturation: (unspecified date) >94, notes: Both of us have remained afebrile, with good pulse oximetry >94; SARS-CoV-2 test: (30Jun2022) positive, notes: After positive test 30Jun, started 5-day course Paxlovid; (05Jul2022) negative, notes: At end of 5-day course 05Jul I tested negative; (10Jul2022) positive, notes: Retested and it had returned to covid-positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Appeared to be Covid rebound. Original Sx (symptoms) onset 29Jun2022, mild bronchitis with exhale wheezing, mild fatigue, a febrile. Positive test 30Jun2022. On 10Jul2022, patient woke up with mild bronchitis again, this time with a mild productive cough with forced expiration wheezing. The retropharyngeal irritation was not present. Afebrile still. Not much fatigue really. Retested and it had returned to covid-positive. One other thing to note: my housemate also turned covid-positive 5 days after I did. Not sure if it is the same strain, but we were probably exposed together. (Housemate is completing a 5-day course of Paxlovid today, but remains covid-positive but otherwise asymptomatic. Both of us have remained afebrile, with good pulse oximetry >94).  Follow-up attempts are completed. No further information is expected.
Hyper & won't sleep-won't take naps x 2 wks never been the best sleeper- (bacterial infection JUN-SEP) was sleeping 10-12 hrs/noc 1-2hr nap; diarrhea x 1 day post vax; past 3 nocs slept thru noc 1hr nap yesterday;
As soon as injection was given, I felt a lot of pain at the time.  I even commented that this pain was more than normal after a vaccine. The pain has continued for three weeks.  It is achy in my left arm (where vaccine was give), radiates to left shoulder blade and down left side of my back.  Limited range of motion; difficult to put shirts on overhead.
Right after getting shot I had not been in good health for about 12 days thereafter, Days 1 & 2 I felt lack luster, I just wanted to be in bed then from there on I began 2 be sick with a different kind of illness everyday. I got a headache, then felt upset stomach then next day a sinus cold. Then a cough, felt as if I had a slight flu at times, is all this from the shot? I also had moved into another house. It could have been that.
Soreness when arm is raised/Pain at site and area when arm is raised; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number GZ29L, expiry date 23rd May 2021) for prophylaxis.   On 31st July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were reported as follows: The pharmacist asked if any information available as the patient experienced soreness and pain at the site and area when patient raises arm. The patient has to support arm.  The reporter had consented to follow up.
Vaccine was administered into rotator cuff instead of deltoid causing sever shoulder pain, inability to lift, twist and properly use left arm with or without added weight. Unable to do simple tasks throughout the day and at work.  Pain has gotten much worse over time.
This is a spontaneous report from a contactable consumer (patient). This is one of the 3 cases from same reporter. A 48-years-old female patient received second dose of bnt162b2 (COVID-19 mRNA VACCINE, Solution for injection, Lot /Batch Number: ER8736 and expiry date was not reported) via an unspecified route of administration in left deltoid at left upper shoulder on 17May2021 (at age 48-years-old) as a single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. No relevant family medical history was reported. No Prior Vaccinations within 4 weeks. No additional vaccine was administered on same date. Patient had previously received first dose of vaccine (LOT: ER8733; EXP: unknown) in left upper shoulder on 26Apr2021 and experienced fatigue. On 18May2021 (1 day after vaccination), patient was just tired (fatigue) and arm hurt really bad/ Her arm was really sore. She had gotten it in the left arm. She didn't throw up or anything. She was also dizzy and nauseous. Around lunch time, around noon, it really picked up and she got the chills for a short period of time, low grade fever and body aches. On an unknown date in May2021 (reported as the for the next day) She felt lousy. By around noon the next day she was back to normal. She worked half the day and ended up taking the rest of the day off and the next day off to recover. She wasn't scared or worried. No Treatment was received. Patient did not visit emergency room or physician office. Reporter seriousness for all events was unspecified. On an unspecified date in May2021, the patient resolved from the event "felt lousy". The outcome of other events was unknown. Additional information has been requested.
1/30: Fever, chills, body aches, arm soreness, dizziness, headache, fatigue, nausea 1/31: Arm soreness, headache, fatigue, nausea, dizziness 2/1-2/4: headache, dizziness, fatigue 2/5: Fatigue, "weirdness" feeling, dry throat 2/6: Dry throat, couch, difficulty breathing  2/7: increase in 2/6 symptoms; weight in chest feeling
Pox noted on legs, trunk, face and arms. Fever 104.3 (R), nausea and vomiting. Doctor stated no seizures but had shaking spells. AST at admission 221 and ALT 160. Decreased during hospitalization. On day of dismissal, AST 193 and ALT82. Nursing staff at hospital reported only few pustules. Stated most appeared to be under skin and no eruption. Treatment with Rocephin 500mg IM for 2 doses. Tylenol PRN and Children's Advil.
This is a 42 year old yo female  with Past Medical History and problems noted below who presents  With concerns of missed period x2 months  She is sexually active , notes that she is trying to get pregnant  Negative pregnancy test  Reports hot flashes x 1 month   28 day cycle  lmp 04/5/21  Denies history of similar symptoms  Reports previously normal menstrual cycle up until covid vaccination with pfizer  on 3/8/21 and 4/5/21 . She reports that she was on her cycle during both vaccinations and since then , has not had her menstrual cycle  No mood changes  No weight changes , galactorrhea
confirmed case of pertussis; recvd vax on 7APR92-1S31033, 10JUN92 2H31039 & 12AUG92-2K31068; sister who had 4 doses also has poss infection;
swelling of the upper arm (from shoulder to elbow)  that was injected with heat to area, lasted 14 days; fatigue and malaise, continuous headache, flu like symptoms lasting 4 days, treated with ibuprofen and Tylenol with negative effects.
Patient started feeling dizzy, lightheaded, slit rash and see finger prints in vision.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown demographics. On unknown dates the patients received unspecified number of doses of improperly stored PEDVAXHIB. The nurse reported that the doses may have been given from the following lots: Lot # M014926 (expiry date: 17-FEB-2019), Lot # reported as M025194 (expiry date: 22-MAR-2019) and Lot# M007762 (expiry date: 07-DEC-2017). No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A2) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that no treatment was provided to the patients. Concomitant medication was not reported. It was reported that the vaccine was stored in the freezer and they would take out one to two vials and keep in the fridge as needed each day.
Right lateral thigh - Erythrocyte with moderate swelling 7cm diameter with small (4mm) erythema spots around it.
I82.431 ACUTE DVT OF RIGHT POPLITEAL VEIN 2/25/2021 LEFT HUMERUS PATHOLOGICAL FX, ROUT SUBSEQ
Patient showed up with rash/swollen arm. Was told to check with MD. MD was informed. Was put on BENADRYL.
- Pain at the injection site lasting ~2 days after vaccine administration [expected] - Delayed Injection site reaction occurring ~1 wk after administration. Lasted a few days before resolving on it's own (no meds used) Red, painless, ~1.5-2 in in diameter.  Not raised.  - Periodic, sharp headaches. Short in duration however appear to occur almost daily since injection. Location: forehead/above eyes
Patient received another Pfizer Bivalent booster after two months receiving their first Pfizer Bivalent booster. Patient has body aches, headaches, and joint pains. Patient's body feels heavy.
This spontaneous report as received from a physician refers to 22 patients of unknown age and unknown gender. Pertinent medical history, drug reactions or allergies were not reported. On 2014, from 02-FEB-2014 to July 2014, the 22 patients were vaccinated (reported as could have been administered to 22 patients) with PROQUAD lot # J015595, expiration date 05-JUN-2015, that were exposed to highest temperature of 5 degrees C (reported as "5C") for 5 months (strength, dose and dose schedule were not reported). No concomitant therapies were reported. No adverse effects reported. The outcome of the events was unknown. Additional information has been requested.
shortness of breath, hives, tachacardia, swelling of tongue lip and itchy, tight throat
Information has been received from a physician concerning a 23 year old female patient with no pertinent medical history, drug reactions or allergies reported, who on 02-DEC-2009 was vaccinated with a first dose of GARDASIL, into the left deltoid muscle (intramuscular route, lot # 661953/1130X). Concomitant therapy included birth control pills. On 02-DEC-2009 the patient developed a "pea-size, itchy lump" at the injection site. No lab diagnostic studies performed. The patient sought unspecified medical attention. On 02-JAN-2010, the patient recovered. Additional information has been requested.
She had syncope, nausea, vomiting on 2/10/21, 4 days after vaccine. She went to ED that day. She saw me today (3/4/21) and has had recurrent nausea, vomiting and dizziness but no further syncope.
had a rash all over his body; This is a spontaneous report from a contactable other hcp. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced had a rash all over his body on an unspecified date. Caller stated a patient who's after getting the first vaccine shot had a reaction 3 days later, he developed a rash, he was asymptomatic he feels fine. Caller wanted to know if patient can get his second dose of the COVID-19 vaccine. Caller went to the CDC website and he didn't see where indicated if it was okay for this person to get the second vaccine. The outcome for the event was unknown.  Information on Lot/Batch has been requested.  Follow-up attempts are completed. No further information is expected.
I developed this noise in my ear (a rushing water sound). I called the tele nurse. She advised me take my blood pressure if I had a bp monitor available and I did. I took my blood pressure and it was really high. The nurse told me I needed to go to a medical facility. I went to urgent care. They took my blood pressure and it was extremely high. They sent me to the emergency room because they thought I was having a stroke. I took several tests as well and was told I had hypertension. I am currently on blood pressure medication now. Most of the time, my blood pressure is controlled and sometimes it spikes.
Information has been received from a health professional concerning a 36 year old female who on Apr 22 2005 was vaccinated with an intradermal dose of hepatitis B vaccine rHBsAg (yeast) (+) Hib conj vaccine. it was reported that the patient developed a mark similar to what a positive PPD test looks like but was otherwise asymptomatic. No product quality complaint was involved. Additional information has been requested.
Patient  presented new onset slurred and garbled speech with difficulty  understanding others, right arm weakness, numbness.  Pt experience gran mal seizure during CT scan at admission.  Activated as stroke code, but but it was determined that her symptoms  were likely due to seizures. Pt recovered from the expressive aphasia and right arm symptoms, but  developed moderate paresthesia and orthostatic hypotension. Released on neurological and stroke follow up,
Sinusitis; Swelling at injection site; This spontaneous case was reported by a patient and describes the occurrence of SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L204) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site). The patient was treated with LEVOTHYROXINE SODIUM (SYNTHROID) at a dose of UNK dosage form; ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) at a dose of UNK dosage form and LISINOPRIL at a dose of UNK dosage form. At the time of the report, SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Extreme pain in arm at shot location, unable to lift arm for two days above her heart level.  On 09/23/2009 patient had the diarrhea, severe stomach cramps and fainted, falling off toilet into my arms. Patient was mumbling and unaware of what was happening. Patient pale, cold, clammy skin, lips white.  Able to get her into bed and color started to come back. Had patient drink water slowly. Within 30 minutes patient was back to normal but still had the diarrhea with severe stomach cramps for several hours off and on.  If I would not have been in the bathroom with her the first time she would have hit her head on the bathtub when she fainted. She could have easily have inured herself in the fall. I have no intentions of ever getting the H1N1 shots/mist for her or any other flu shot for her entire life. I work in a hospital and do not plan on getting the flu shots either, not tested enough and any chance of adverse reactions is a major concern.
Recieved the smallpox vaccine on 30Jul08. On 15Aug08, developed a rash on hands, wrist, elbows and bottom of feet. Patient went to clinic and referred to Derm. DX Viral Exantham R/T smallpox vaccination.
Severely swollen arm All around Armpit swollen tingling in fingers  Fever 101.5 Chills Sweats  Swelling increasing down arm over three days  Extremely red Fatigue  Arm is hot to touch
Inflammatory marker increased; JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS; JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATORY MARKER INCREASED (Inflammatory marker increased), NAIL PITTING (JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS) and ONYCHOLYSIS (JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    The patient's past medical history included Joint pain (7 years) from 01-Jan-2010 to 01-Jan-2017. Concurrent medical conditions included Penicillin allergy and Psoriatic arthritis.   In 2010, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLAMMATORY MARKER INCREASED (Inflammatory marker increased), NAIL PITTING (JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS) and ONYCHOLYSIS (JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS). At the time of the report, INFLAMMATORY MARKER INCREASED (Inflammatory marker increased) had not resolved and NAIL PITTING (JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS) and ONYCHOLYSIS (JOINT PAIN IN MANY AREAS SUCH AS FINGERNAILS/PITTING AND SEPARATION FROM NAIL BED, SHOULDERS, ELBOWS) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Inflammatory marker test: Inflammatory marker increased.         No concomitant medication was provided  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   From 01-Jan-2010 to 01-Jan-201, the patient had joint pain in many areas such as fingernails/pitting and separation from nail bed, shoulders, elbows.  The reporter's causality for the event(s) of inflammation level increased and joint pain onset 01-Jan-2010 with Humira(adalimumab) was no reasonable possibility. the reporter's causality for the nail pitting and Onycholysis was not provided.  No treatment details were provided.
Had a sore right arm for a few days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Had a sore right arm for a few days) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Had a sore right arm for a few days). On 03-Apr-2021, PAIN IN EXTREMITY (Had a sore right arm for a few days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were provided.  No treatment medications were reported.   This case was linked to MOD-2022-450402, MOD-2022-450403 (Patient Link).
Left arm swollen 07/29/04. Rashes.  08/11/04-vaccine given 08/04/04.